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Objective. To compare the level of pain experienced by patients during transrectal
ultrasound-guided prostatic biopsy using intrarectal 2% lidocaine gel versus plain
lubricant gel.
Design. Prospective double-blind randomised controlled trial.
Setting. Regional hospital, Hong Kong.
Patients. From March 2002 to December 2003, patients who underwent
ultrasound-guided prostate biopsy at a Geriatric Urology Centre.
Main outcome measures. Pain and discomfort scores measured by horizontal
visual analogue scales.
Results. A total of 338 consecutive patients were randomised to lidocaine gel
or plain lubricant gel groups. The two groups were statistically similar in demo-
graphic and disease characteristics. There were no significant statistical differ-
ences in pain or discomfort score in the lidocaine gel and plain lubricant
groups—pain score: 1.75 versus 1.79 (P=0.66) on day 0 and 0.21 versus 0.15
(P=0.97) on day 1; discomfort score: 0.79 versus 0.77 (P=0.86) on day 0 and
0.12 versus 0.12 (P=0.76) on day 1. No major complications were recorded in
this cohort.
Conclusions. Transrectal ultrasound-guided trucut biopsy of the prostate can
be safely performed with no anaesthesia in Chinese patients. Pain and discomfort
are minimal. It was found that 2% lidocaine gel has no statistical therapeutic or
analgesic benefit over plain lubricant gel.
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Introduction
Transrectal ultrasound (TRUS)-guided needle biopsy of the
prostate gland is considered a simple and accurate method
by which prostatic tissue is obtained for histological
evaluation.1-3 It was estimated that 232 090 new cases of
prostate cancer would be diagnosed in 20054 in the United
States and TRUS-guided biopsy is the current diagnostic
gold standard. With an average positive biopsy rate of
30%, more than 770 000 biopsies will be performed
annually. In Hong Kong, 912 new cases of prostate cancer
were diagnosed in 2002; prostate cancer was the fourth most
common cancer in men.5 Various forms of anaesthesia,
including lidocaine nerve blockade,6-8 intrarectal lidocaine
gel,9 and nitrous oxide inhalation,10,11 have been reported to
effectively decrease patient pain and discomfort during
TRUS-guided prostate biopsy. Nonetheless, there is no
consensus on optimum analgesia during the procedure.
Many studies have not been prospective, measurement of
pain has not been standardised or objective, and urologists
have not been blinded to the type of anaesthesia used. In
addition, previous experience of biopsy and cultural factors
may affect patient perception of pain and discomfort. We
evaluated the pain and discomfort levels associated with
TRUS-guided prostate biopsy with intrarectal administration
of 2% lidocaine gel versus plain lubricant gel alone in a
prospective double-blind randomised controlled trial.
Methods
Patients
In this prospective study, patients at the Geriatric Urology
Centre, Department of Surgery, University of Hong Kong
Medical Centre, Tung Wah Hospital were enrolled between
March 2002 and December 2003. The study population
consisted of consecutive patients referred for urology
advice because of a raised prostate-specific antigen (PSA)
level on screening or lower urinary tract symptoms and raised
PSA or abnormal digital rectal examination (DRE). All
patients with PSA level of above 4 ng/mL or abnormal DRE
were enrolled in the study. Patients were excluded from
analysis if they had a history of previous biopsy, were non-
Chinese, or were currently prescribed analgesia.
Study design
A clinical history was obtained from all patients. Following
physical examination, patients were randomly assigned,
by drawing a pre-sealed envelope, to a group who would
receive 2% lidocaine gel 10 mL or plain lubricant gel
10 mL intrarectally. The procedure was explained to
patients by a nurse specialist and they were given written
information for future reference. All patients commenced a
3-day course of oral antibiotic prophylaxis 1 day prior to
the procedure: ciprofloxacin 250 mg twice a day and
metronidazole 400 mg 3 times a day. Patients were instructed
to use fleet enema (sodium biphosphate) to clear the
lower bowel before biopsy. Informed consent was obtained
from all patients.
Patients were placed in the left lateral decubitus
position with the knees and hips fully flexed. Plain lubricant
gel or 2% lidocaine gel (Instillagel; Farco-Pharma GmbH,
Cologne, Germany) was gently instilled into the rectal vault
and onto the perianal area. After 5 minutes, a 7-MHz
ultrasound probe (Falcon 2002; B & K, Copenhagen,
Denmark), 22 mm in diameter (Fig 1), was used to
examine and measure the prostate gland. Total prostate
volume was determined using a computer-generated
elliptical estimation of volume (volume=0.52 x transverse
diameter [W] x anteroposterior diameter [H] x cranial
caudal diameter [L]). The TRUS-guided systematic
biopsies were performed during sagittal scanning with an
18-gauge biopsy cut needle (ACN Biopsy needle;
MDTECH, Florida, US) driven by a spring-loaded Bard
Biopsy gun (CR Bard Inc, Covington, Georgia, US). A
systematic sextant pattern was used with biopsies taken at
the base, middle, and apex of the right and left lobes at the
parasagittal plane. In addition, two lateral horn biopsies
were performed on each side. The biopsy gun was reloaded
by an assistant after each biopsy. The gun was fired with
the needle pointing to the mouth of an empty, appropriately
labelled specimen container. The specimen was expelled,
by firing the gun, into the sterile container intact with no
contamination and further manipulation. On completion of
the biopsy procedure, formalin solution was poured into
the specimen bottle inside the fume cupboard to fix the
tissue. The whole procedure including ultrasound
examination and biopsy took 5 minutes on average. All
procedures were done by or in the presence of one of the
authors in order to ensure the correct method was
employed throughout the study.
Within 5 minutes of completion of the procedure, patients
were asked to grade the pain associated with the ultrasound
and biopsy experience on a horizontal visual analogue
scale (VAS) [Fig 2] and a 4-point discomfort scale
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Fig 1. Scaled illustration of the 7-MHz ultrasound probe
(Falcon 2002; B & K), 22 mm in diameter which was used to
examine, measure, and guide biopsy of the prostate gland
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(Table 1). This was done in another room with the help of a
nurse who had no knowledge on the anaesthesia used.
No attempt was made to separate the grading of pain and
discomfort for different parts of the procedure, such as
DRE, ultrasound probe insertion, or firing of biopsy gun.
Patients were followed up by telephone by the nurse the
following day and asked to report pain and discomfort
scores and whether they experienced any complications
related to the biopsy.
Statistical analysis
The Mann-Whitney U non-parametric rank sum test (two-
tailed) was used to compare continuous variables and
Pearson Chi squared (X2) test (two-sided) was used to
compare dichotomous variables. A P value of less than 0.05
was considered statistically significant. The number of
patients included corresponded to a 95% power (β=0.05),
an alpha risk of 5% (α=0.05, two-sided), and a standard-
ised effective size of 0.4, when a difference in pain score of
0.5 was sought. At least 164 patients were required for
each group. Statistical analysis was performed with the
commercially available Statistical Package for the Social
Sciences (Windows version 11.0; SPSS Inc, Chicago [IL],
US).
Results
From March 2002 to December 2003, a total of 386
consecutive TRUS-guided biopsies of the prostate were
performed. Non-Chinese (n=7) and patients with a history
of previous biopsy (n=41) were excluded. There were 338
eligible patients who were divided into two groups to
receive plain lubricant gel (NA group) or 2% lidocaine
gel (LA group) with 169 patients in each group. Four
urologists performed the biopsies. Each patient received
an extended 10-core biopsy of the prostate with additional
biopsies taken from abnormal sites. The mean age of the
patients was 71.33 years (standard deviation [SD], 7.49
years; range, 49-91 years). The median PSA level was
8.40 ng/mL. The mean volume of prostate was 53.07 mL
(SD, 27.17 mL). Digital rectal examination was normal
in 207 (61.2%) patients. Pathological findings were normal
in 210 (62.1%) cases, 107 (31.7%) had malignancy, 18
(5.3%) had high-grade prostatic intraepithelial neoplasm
(PIN), and three (0.9%) had evidence of inflammatory
changes (Table 2).
There were no statistical differences between the two
groups in terms of age, PSA level, and prostate volume by
Mann-Whitney U test, or pathological findings and DRE
by Pearson Chi squared test (Table 2). The VAS pain
scores and discomfort scores on days 0 and 1 for the two
groups were shown in Fig 3 and 4, respectively. Mann-
Whitney U test showed no statistical difference between
the two groups with the sensitivity of detection of VAS 0.5
points (Table 2).
Table 1.  Discomfort scale
Score Degree of discomfort
0 None
1 Mild
2 Moderate
3 Severe
Table 2.  Demographic data, and pain and discomfort scores
Plain gel group, Lidocaine gel group, P value
n=169 n=169
Mean age (range) [years] 70.99 (49-91) 71.67 (50-91) 0.45
Median serum PSA* (ng/mL) 8.40 (1.80-4735.00) 8.00 (0.17-6740.00) 0.75
Prostate volume (mL)
Mean (SD) 55.02 (29.63) 51.11 (24.38) 0.29
Range 14.00-257.40 14.23-140.00
Digital rectal examination (No. of patients)
Normal 108 99 0.35
Abnormal 161 70
Histology (No. of patients)
Negative 108 (63.9%) 102 (60.4%) 0.81
Cancer 150 (29.6%) 157 (33.7%)
Prostatic intraepithelial neoplasm 119 (5.3%)1 119 (5.3%)1
Inflammation 112 (1.2%)1 111 (0.6%)1
Mean pain score on day 0 (SD) 1.79 (1.51) 1.75 (1.55) 0.66
Mean pain score on day 1 (SD) 0.15 (0.45) 0.21 (0.69) 0.97
Mean discomfort score on day 0 (SD) 0.77 (0.60) 0.79 (0.62) 0.86
Mean discomfort score on day 1 (SD) 0.12 (0.32) 0.12 (0.36) 0.76
* PSA denotes prostate-specific antigen
No pain Worst pain
that patients
can imagine
0 1 2 3 4 5 6 7 8 9 10
Fig 2. Pain scale (0-10 visual analogue pain scale)
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Discussion
In 1963, Takahashi and Ouchi11 first performed transrectal
ultrasonography of the prostate gland, and in 1981 Holm
and Gammelgaard12 described transperineal biopsy of the
prostate guided by TRUS. It was not until 1989 that
Torp-Pedersen and Lee13 reported the results of TRUS-
guided biopsy of the prostate using a spring-loaded 18-
gauge biopsy needle. To date, TRUS-guided biopsy of
the prostate remains the gold standard in diagnosing
prostate cancer. It is estimated that more than 770 000
prostate biopsies would be performed in 2005 in the United
States. Although TRUS-guided biopsy of the prostate is
frequently performed, there is no consensus on optimal
anaesthesia during the procedure. Anaesthetic modalities
such as periprostatic lidocaine block, transrectal lidocaine
gel, intravenous sedation, nitrous oxide inhalation, and
plain lubricant gel are widely used. In this prospective
double-blind randomised study, we identified no statistical
significant difference in the pain and discomfort scores
following intrarectal administration of 2% lidocaine gel or
plain lubricant gel alone.
A 10-point linear VAS is generally considered the best
instrument for assessing pain intensity. It is independent of
language and ethnic differences, provides a sensitive
measurement, and enables statistical comparison. The mean
VAS pain scores were 1.79 (SD, 1.51) and 1.75 (SD, 1.55)
on day 0, and 0.15 (SD, 0.45) and 0.21 (SD, 0.69) on day
1 for NA and LA groups, respectively. These scores
indicate mild pain while a pain score of greater than 5
would be considered to be moderate-to-severe. Mann-
Whitney U test showed no statistical difference between
the two groups with the sensitivity of detection of VAS
0.5 points. Other studies have reported similar findings.14,15
Nonetheless our cohort groups reported less pain compared
with other studies and this may have been due, in part, to
ethnic differences. Our cohort consisted of exclusively
ethnic Chinese patients, recruited consecutively and
prospectively. Other studies have demonstrated that acute
and chronic pain perception is influenced by ethnic and
cultural factors.16-20 Our cohort of ethnic Chinese patients
were more tolerable to pain with a low mean VAS pain
score.
Redelmeier et al21 demonstrated that patients who
experienced pain during colonoscopy may recall the
experience as unpleasant. A repeated procedure would be
biased and preclude the patient from a subsequent
procedure. Repeated TRUS-guided prostate biopsy, similar
to colonoscopy, is significantly influenced by the previous
experience. In the current trial, we excluded  patients with a
history of previous biopsy in order to allow a more object-
ive assessment of pain and discomfort scores.
The second end-point of the current study was discom-
fort score for the whole procedure. As instrumentation and
manipulation at the anal canal may not cause pain but
discomfort, the 4-point discomfort scale (Table 1) meas-
ured patient’s general feeling for the whole procedure. The
mean discomfort scores were 0.77 (SD, 0.60) and 0.79 (SD,
0.62) on day 0, and 0.12 (SD, 0.32) and 0.12 (SD, 0.36) on
day 1 for NA and LA groups, respectively. Mann-Whitney
U test showed P values of 0.86 and 0.76 on day 0 and day 1,
respectively. There was no statistical significant difference
between two groups.
In this trial, we did not purposely stratify pain and
discomfort for various parts of the procedure, namely DRE,
introduction of ultrasound probe into the rectum, trucut
biopsy of the prostate, and withdrawal of the ultrasound
probe. Nevertheless urologists who performed the proce-
dure had the general impression that the introduction of
the ultrasound probe caused the most discomfort or pain
during the whole procedure. As the current ultrasound
probe is 22 mm in diameter, it would be worth investigating
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Fig 3. Visual analogue scale (VAS) pain scores of the plain
lubricant gel (NA) and 2% lidocaine gel (LA) groups after
transrectal ultrasound-guided trucut biopsy of the prostate
gland on day 0 (P=0.66) and day 1 (P=0.97)
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Fig 4. Discomfort scores of the plain lubricant gel (NA) and
2% lidocaine gel (LA) groups after transrectal ultrasound-
guided trucut biopsy of the prostate gland on day 0 (P=0.86)
and day 1 (P=0.76)
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whether use of a smaller size probe can minimise pain and
discomfort.
Each tube of 2% lidocaine gel (Instillagel; Farco-Pharma
GmbH) costs HKD25. As there were no benefits to using
this gel, financial savings are possible if only plain gel is
used.
The data in this study demonstrated that TRUS-guided
biopsy of the prostate without anaesthesia is safe and well
tolerated by Chinese patients. No patient experienced a
vasovagal attack, hypotension, severe bleeding, sepsis, or
loss of consciousness during or after the procedure. Further
studies are required to determine whether use of a smaller
ultrasound probe reduces the minimal pain and discomfort
experienced.
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